CJC-1295 No-DAC vs IGF-1 DES — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 No-DAC (also called Modified GRF 1-29 or Mod GRF) is a short-acting GHRH (Growth Hormone-Releasing Hormone) analog consisting of the first 29 amino acids of endogenous GHRH with four amino acid substitutions to improve stability and receptor binding....
Calculate CJC-1295 No-DAC dose →IGF-1 DES (des(1-3)IGF-1) is a naturally occurring truncated form of IGF-1, produced endogenously in the brain and other tissues, that lacks the first three N-terminal amino acids (Gly-Pro-Glu) of full-length IGF-1. This truncation eliminates its binding to IGF-binding proteins (...
Calculate IGF-1 DES dose →| Parameter | CJC-1295 No-DAC | IGF-1 DES |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | Research Use |
| Half-Life | 30 minutes | 20–30 minutes (shorter than IGF-1 LR3) |
| Typical Dose | 100–200 µg | 50–100 µg |
| Frequency | 2–3x daily | 1–2x daily (peri-workout) |
| Route | Subcutaneous | Subcutaneous / Intramuscular (local) |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.